GlassScriptPhysician profile
Sandeep Gupta
NPI 1063500353
$118,147.91
in general payments reported to CMS, 2019-2025
38 companies · $1,652 in 2025
The $1,652 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $15K · 2021: $21K · 2022: $39K · 2023: $18K · 2024: $1,394 · 2025: $1,652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $5,597 · Travel and Lodging: $2,695 · Education: $68.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,690.00 |
| Food and Beverage | $5,597.26 |
| Travel and Lodging | $2,694.90 |
| Education | $68.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $93,176.77 | 2019-2024 | Xarelto |
| Insmed, INC. | $6,851.48 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $5,973.41 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $3,271.88 | 2019-2023 | Stiolto Respimat, Ofev |
| Abbott Laboratories | $3,113.83 | 2023 | Ensite Precision |
| Glaxosmithkline, LLC. | $1,844.99 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,786.56 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Genzyme Corporation | $572.05 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $300.64 | 2021-2025 | Dupixent |
| Ethicon US, LLC | $145.19 | 2025 | Surgiflo Hemostatic Matrix |
| Intuitive Surgical, INC. | $123.22 | 2024 | |
| Itamar Medical INC | $105.56 | 2025 | Watchpatone |
| Optinose US, INC. | $79.14 | 2019-2022 | |
| Mylan Specialty L.P. | $78.03 | 2019-2024 | Yupelri |
| Pfizer INC. | $70.95 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $57.39 | 2022-2023 | Smartvest |
| Sanofi-Aventis U.S. LLC | $54.95 | 2023 | |
| Shionogi INC | $48.17 | 2023-2024 | Fetroja |
| Actelion Pharmaceuticals US, INC. | $47.08 | 2020-2025 | Opsynvi |
| Inspire Medical Systems, INC. | $43.02 | 2024 | Inspire |
| Lilly USA, LLC | $41.61 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $32.53 | 2022 | |
| Resmed Corp | $31.95 | 2025 | |
| Philips North America LLC | $28.29 | 2023-2024 | (Ak6) Vest Therapy |
| E.R. Squibb & Sons, L.L.C. | $26.65 | 2021-2022 | |
| Pulmonx Corporation | $26.27 | 2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Ani Pharmaceuticals, INC. | $25.81 | 2023 | Purified Cortrophin Gel |
| Amgen INC. | $22.98 | 2022 | |
| Merck Sharp & Dohme LLC | $21.78 | 2023 | |
| Abbvie INC. | $21.29 | 2022 | |
| Baxter Healthcare | $20.58 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Harmony Biosciences LLC | $20.37 | 2025 | |
| Ambu INC. | $20.21 | 2020 | |
| Verona Pharma, INC. | $19.88 | 2025 | Ohtuvayre |
| Phadia US INC. | $16.00 | 2024 | Immunocap |
| United Therapeutics Corporation | $14.85 | 2021 | |
| Circassia INC. | $12.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.